A recent study demonstrated that the m6A reader YTHDF2 specifically stabilizes MYC mRNA in cancer stem cells and that YTHDF2 provides a therapeutic target to interfere with MYC signaling in GBM (Dixit et al., 2021). The gene discussed is YTHDF2; the disease is glioblastoma.